Synbio Digest features news, views and reports covering the synthetic biology industry and recent research. 5th November 2018 Headlines: Budget risks reducing company R&D tax credits whilst increasing govt R&D spend. Blue bugs. Budget 2018. Chancellor Philip Hammond announced increases to R&D spending and commitment to investing 2.4% of GDP in R&D by 2027. The […]
read moreUKI2S announced in August the successful exit of its portfolio company Quethera. Acquired by Japanese pharma giant Astellas for up to £85 million, the deal sees Quethera’s novel ophthalmic treatment program continue under the new parent. How did this successful exit come about in under three years since first raising funds? Quethera was founded by […]
read moreEagle Genomics has landed a prestigious co-sell partnership with Microsoft for their knowledge discovery platform. The deal will see the UKI2S-supported company gain access to global enterprise leaders through the Microsoft sales team. The announcement comes on the back of the company’s successful graduation from the Microsoft ScaleUp programme, previously known as the Microsoft Accelerator. […]
read more